Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ digital
    • Subscribe to CMAJ print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ digital
    • Subscribe to CMAJ print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Practice
Open Access

Antipsychotic medications for older adults with delirium admitted to hospital

Christina Reppas-Rindlisbacher, Lesley Wiesenfeld and Nathan M. Stall
CMAJ August 14, 2023 195 (31) E1038-E1039; DOI: https://doi.org/10.1503/cmaj.230227
Christina Reppas-Rindlisbacher
Division of General Internal Medicine and Geriatrics (Reppas-Rindlisbacher, Stall), Sinai Health System and the University Health Network; Women’s College Research Institute (Reppas-Rindlisbacher, Stall), Women’s College Hospital; Department of Medicine (Reppas-Rindlisbacher, Stall) and of Psychiatry (Wiesenfeld), University of Toronto; Division of Psychiatry (Wiesenfeld), Sinai Health System, Toronto, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lesley Wiesenfeld
Division of General Internal Medicine and Geriatrics (Reppas-Rindlisbacher, Stall), Sinai Health System and the University Health Network; Women’s College Research Institute (Reppas-Rindlisbacher, Stall), Women’s College Hospital; Department of Medicine (Reppas-Rindlisbacher, Stall) and of Psychiatry (Wiesenfeld), University of Toronto; Division of Psychiatry (Wiesenfeld), Sinai Health System, Toronto, Ont.
MD MHCM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan M. Stall
Division of General Internal Medicine and Geriatrics (Reppas-Rindlisbacher, Stall), Sinai Health System and the University Health Network; Women’s College Research Institute (Reppas-Rindlisbacher, Stall), Women’s College Hospital; Department of Medicine (Reppas-Rindlisbacher, Stall) and of Psychiatry (Wiesenfeld), University of Toronto; Division of Psychiatry (Wiesenfeld), Sinai Health System, Toronto, Ont.
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

For an account of delirium from the perspective of a patient’s wife and daughter see www.cmaj.ca/lookup/doi/10.1503/cmaj.230833

Antipsychotic medications are commonly used in hospital for the management of patients with delirium

Delirium occurs in 30%–50% of adults aged 65 years or older admitted to hospital, and may be hypoactive (lethargy, reduced psychomotor functioning), hyperactive (agitation, hallucinations) or mixed.1 Twenty-nine percent of patients with delirium admitted to hospital in the United States are newly started on antipsychotic medications.2

Antipsychotic medications should not be used as standard treatment for delirium

Delirium management includes addressing underlying causes, optimizing environmental factors and implementing nonpharmacologic interventions.1 A 2019 systematic review reported no difference between antipsychotic medications and placebo on delirium duration or severity, length of hospital stay or mortality.3 Most studies did not differentiate hypoactive from hyperactive delirium or examine the impact of antipsychotic medications on patient and family experience.

Antipsychotic medications may be considered for patients with delirium experiencing severe agitation or distress

Antipsychotic medications may be used for patients with delirium who are at risk of self-harm, harming others or compromising essential medical therapy, or for patients with psychotic symptoms experiencing substantial distress.4 They are preferred over benzodiazepines, except for specific indications such as delirium associated with alcohol or benzodiazepine withdrawal.1 Antipsychotic medications should not be used for hypoactive delirium.4

Assessment of individual risks and benefits is warranted prior to use given serious adverse effects

The adverse effects of antipsychotic medications include sedation, hypotension, falls, parkinsonism, QT interval prolongation and aspiration pneumonia.4 Antipsychotic selection should consider adverse effects, desired outcome, relative contraindications and preferred administration routes (Appendix 1, available at www.cmaj.ca/lookup/doi/10.1503/cmaj.230227/tab-related-content).

Frequent reassessment of treatment should be undertaken for dose reduction or discontinuation

Many patients are discharged from hospital on newly prescribed antipsychotic medications without a clear indication for ongoing treatment.5 They should be prescribed at the lowest effective dose for the shortest possible duration and be reevaluated at or shortly after discharge.

Footnotes

  • Competing interests: Christina Reppas-Rindlisbacher reports support from the Canadian Institutes of Health Research Vanier Scholarship Program and the Eliot Phillipson Clinician-Scientist Training Program at the University of Toronto. Lesley Wiesenfeld reports institutional support as the chief of psychiatry at Sinai Health and an honorarium for speaking at a geriatric psychotherapy national conference. She is chair of the Mental Health and Incapacity panel for the College of Physicians and Surgeons of Ontario. No other competing interests were declared.

  • This article has been peer reviewed.

  • Disclaimer: Nathan Stall is an associate editor with CMAJ and was not involved in the editorial decision-making for this article.

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

References

  1. ↵
    1. Marcantonio ER
    . Delirium in hospitalized older adults. N Engl J Med 2017;377: 1456–66.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Herzig SJ,
    2. Rothberg MB,
    3. Guess JR,
    4. et al
    . Antipsychotic medication utilization in nonpsychiatric hospitalizations. J Hosp Med 2016;11:543–9.
    OpenUrl
  3. ↵
    1. Nikooie R,
    2. Neufeld KJ,
    3. Oh ES,
    4. et al
    . Antipsychotics for treating delirium in hospitalized adults: a systematic review. Ann Intern Med 2019;171:485–95.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Inouye SK,
    2. Marcantonio ER,
    3. Metzger ED
    . Doing damage in delirium: the hazards of antipsychotic treatment in elderly persons. Lancet Psychiatry 2014;1: 312–5.
    OpenUrl
  5. ↵
    1. Herzig SJ,
    2. Rothberg MB,
    3. Guess JR,
    4. et al
    . Antipsychotic use in hospitalized adults: rates, indications, and predictors. J Am Geriatr Soc 2016;64:299–305.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 195 (31)
CMAJ
Vol. 195, Issue 31
14 Aug 2023
  • Table of Contents
  • Index by author

Article extras

  • Version française

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antipsychotic medications for older adults with delirium admitted to hospital
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Antipsychotic medications for older adults with delirium admitted to hospital
Christina Reppas-Rindlisbacher, Lesley Wiesenfeld, Nathan M. Stall
CMAJ Aug 2023, 195 (31) E1038-E1039; DOI: 10.1503/cmaj.230227

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Antipsychotic medications for older adults with delirium admitted to hospital
Christina Reppas-Rindlisbacher, Lesley Wiesenfeld, Nathan M. Stall
CMAJ Aug 2023, 195 (31) E1038-E1039; DOI: 10.1503/cmaj.230227
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Antipsychotic medications are commonly used in hospital for the management of patients with delirium
    • Antipsychotic medications should not be used as standard treatment for delirium
    • Antipsychotic medications may be considered for patients with delirium experiencing severe agitation or distress
    • Assessment of individual risks and benefits is warranted prior to use given serious adverse effects
    • Frequent reassessment of treatment should be undertaken for dose reduction or discontinuation
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Delirium: perspectives of a patient’s wife and daughter
  • Antipsychotiques pour les personnes âgées hospitalisées atteintes de délirium
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Asexuality
  • Berylliosis in a 56-year-old welder
  • Pseudohyperkalemia in chronic lymphocytic leukemia
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Cognitive impairment (not dementia)
    • Dementia & Alzheimer disease
    • Drugs: adverse reactions
    • Drugs: psychotherapeutic
    • Emergency medicine
    • Geriatric medicine
    • Internal medicine
    • Psychiatry & mental health: adult
    • Psychiatry & mental health: geriatric

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire